An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization
Status unconfirmed · Phase 4 · Has a placebo group
Conditions studied: Covid19
In brief
The purpose of this Clinical trial is to explore the therapeutic benefits of Ivermectin and Doxycycline in different combinations in high risk patients diagnosed with COVID-19.
Key facts
- Study ID
- NCT04729140
- Run by
- Max Health, Subsero Health
- People needed
- 150
- Starts
- 2020-12-28
- Expected to finish
- 2022-03-28
- Last updated by the study team
- 2021-04-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age greater than or equal to 18
- Willing and able to provide verbal /telephonic/Personal or computer based Informed Consent
- Experiencing symptoms of COVID-19 illness and tested positive for SARS CoV-2 with either PCR, NAAT or antigen testing
- Residents in a Nursing Home or long-term care facility
- Immunocompromised state, including solid organ transplant, HIV infection, other immune deficiency, immunosuppressant medication including systemic corticosteroids
- Chronic lung disease, including Chronic Obstructive Pulmonary Disease (COPD), moderate to severe asthma, cystic fibrosis, pulmonary fibrosis
- Cardiovascular Disease
- Cancer
- Hypertension
- Obesity (body mass index [BMI greater then or equal to 30 kg/m\^2]
- Diabetes Mellitus
- Chronic Kidney Disease
- Chronic Liver Disease
- Cerebrovascular Disease
- Neurological Disorders including dementia
- Tobacco use disorders
- Hematologic disorders, including sickle cell disease and thalassemia
- We are also interested in including a vital population to protect, considered essential workers who may not fit into the above inclusion criteria:
- Health care professionals and firefighters.
- Government officials or employees.
- Students and teachers.
- Law enforcement agents and personnel.
- Individuals who live with, and cannot isolate, from any of the above groups.
You may not qualify if…
- Participants under the age of 18
- Received any COVID vaccine within the last 30 days
- Contraindications to Ivermectin or Doxycycline
- History of Seizure Disorder or Epilepsy
- History of Myocardial Infarction or Heart Attack within the last one month
- Already receiving Ivermectin or Doxycycline for treatment of any other disease or disorder
- Allergies to Ivermectin or Doxycycline including angioedema, severe asthma, exfoliative dermatitis, Steven Jonson syndrome or psoriasis
- History of angioedema, exfoliative dermatitis, Steven Johnson syndrome, psoriasis
- Currently Pregnant or planning to conceive soon
- Breastfeeding
- History of prior Clostridium Difficile infection
Where it is running
- MAX HEALTH, Subsero Health 2055 Wood Street, Suite 100 — Sarasota, Florida, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.